Fineline Cube

Follow:
14778 Articles
CompanyDeals

Dongcheng Pharma Moves to Enhance Portfolio with Acquisition of Rongcheng Medical’s GSA Injection

Johnson & Johnson's Akeega Approved in China as First Dual Action Tablet for mCRPC
CompanyDrug

Johnson & Johnson’s Akeega Approved in China as First Dual Action Tablet for mCRPC

Everest Medicines' Nefecon Approved in Taiwan for Primary IgAN Treatment
CompanyDrug

Everest Medicines’ Nefecon Approved in Taiwan for Primary IgAN Treatment

BeiGene's Tevimbra Approved in China for NSCLC Patients as Neoadjuvant and Adjuvant Therapy
CompanyDrug

BeiGene’s Tevimbra Approved in China for NSCLC Patients as Neoadjuvant and Adjuvant Therapy

Tianjin Municipality Unveils Plan to Boost Synthetic Biology and Biomanufacturing Innovation
Policy / Regulatory

Tianjin Municipality Unveils Plan to Boost Synthetic Biology and Biomanufacturing Innovation

Novo Nordisk's Alhemo Receives CHMP Recommendation for Haemophilia Prophylaxis in Europe
CompanyDrug

Novo Nordisk’s Alhemo Receives CHMP Recommendation for Haemophilia Prophylaxis in Europe

Stem-Cell Startup Xellsmart Secures Over RMB 100 Million in Series B1 Financing for Neurological Therapies
CompanyDeals

Stem-Cell Startup Xellsmart Secures Over RMB 100 Million in Series B1 Financing for Neurological Therapies

Novartis's Kisqali Receives Positive CHMP Opinion for Early Breast Cancer Treatment in the EU
CompanyDrug

Novartis’s Kisqali Receives Positive CHMP Opinion for Early Breast Cancer Treatment in the EU

Kanghong Pharmaceutical's NASH Drug KH629 Approved for Clinical Trials in China
CompanyDrug

Kanghong Pharmaceutical’s NASH Drug KH629 Approved for Clinical Trials in China

Huadong Medicine Gets Green Light for HPK1 PROTAC Drug HDM2006 in Advanced Solid Tumors
CompanyDrug

Huadong Medicine Gets Green Light for HPK1 PROTAC Drug HDM2006 in Advanced Solid Tumors

China's NHSA Concludes Pre-Negotiation Talks for National Reimbursement Drug List
Policy / Regulatory

China’s NHSA Concludes Pre-Negotiation Talks for National Reimbursement Drug List

Astellas Pharma's Vyloy Receives FDA Approval for Gastric Cancer Treatment in CLDN18.2 Positive Tumors
CompanyDrug

Astellas Pharma’s Vyloy Receives FDA Approval for Gastric Cancer Treatment in CLDN18.2 Positive Tumors